Lightbridge (LTBR)
NASDAQ:LTBR
LTBR Stock Chart & Stats
$15.17
-$0.50(-8.68%)
At close: 4:00 PM EST
$15.17
-$0.50(-8.68%)
Day’s Range― - ―
52-Week Range$6.85 - $31.34
Previous CloseN/A
Volume503.45K
Average Volume (3M)831.18K
Market Cap
$370.55M
Enterprise Value$79.30M
Total Cash (Recent Filing)$201.86M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.38
Next Earnings
May 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding34,152,060
10 Day Avg. Volume657,650
30 Day Avg. Volume831,183
Financial Highlights & Ratios
PEG Ratio12.82
Price to Book (P/B)1.53
Price to Sales (P/S)0.00
P/FCF Ratio-21.70
Enterprise Value/Market Cap0.21
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-4.69
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet & Large CashA debt-free capital structure plus a sharply larger equity/cash base provides durable financial flexibility to fund multi-year R&D, testing, and licensing without near-term leverage pressures. This extends runway for milestone-driven commercialization and reduces refinancing risk while execution continues.
ATR Irradiation Testing StartedCommencement of ATR irradiation is a structural technical milestone that generates regulator-relevant burnup and performance data. Successful irradiation and subsequent post-irradiation exams materially de-risk qualification and underpin long-term licensing and commercial adoption across reactor operators and fuel fabricators.
Expanded INL Workstream & Peer-reviewed PapersBroader INL collaboration and peer-reviewed TopFuel publications strengthen technical credibility with regulators, utilities, and fabricators. This persistent body of validated analysis improves the company's structural ability to secure partnerships and regulatory acceptance needed for commercial licensing and market entry.
Bears Say
Pre-commercial; No RevenueThe company remains without product revenue, reflecting a multi-stage commercialization path that can take years. Persistent lack of sales means reliance on capital markets or partners for funding and indicates that long-term profitability and cash generation are unproven and contingent on successful qualification and licensing.
Regulatory & Qualification Timeline RiskRegulatory approval is a structural gating factor for commercial fuel deployment. Delays, extended data requirements, or unfavorable findings from post-irradiation exams can materially extend time to revenue and increase program costs, making regulatory progress a persistent execution risk for the business model.
Ongoing Cash Burn And Reliance On Equity FundingDespite a larger cash cushion, the company continues to burn operating cash for R&D and team build-out. Reliance on a sizable aftermarket equity raise to fund operations highlights potential dilution risk and the possibility of further capital needs until commercial revenues or nondilutive contracts materialize.
Lightbridge News
LTBR FAQ
What was Lightbridge’s price range in the past 12 months?
Lightbridge lowest stock price was $6.85 and its highest was $31.34 in the past 12 months.
What is Lightbridge’s market cap?
Lightbridge’s market cap is $370.55M.
When is Lightbridge’s upcoming earnings report date?
Lightbridge’s upcoming earnings report date is May 13, 2026 which is in 30 days.
How were Lightbridge’s earnings last quarter?
Lightbridge released its earnings results on Feb 25, 2026. The company reported -$0.215 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.215.
Is Lightbridge overvalued?
According to Wall Street analysts Lightbridge’s price is currently Overvalued.
Does Lightbridge pay dividends?
Lightbridge does not currently pay dividends.
What is Lightbridge’s EPS estimate?
Lightbridge’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lightbridge have?
Lightbridge has 34,152,060 shares outstanding.
What happened to Lightbridge’s price movement after its last earnings report?
Lightbridge reported an EPS of -$0.215 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.653%.
Which hedge fund is a major shareholder of Lightbridge?
Currently, no hedge funds are holding shares in LTBR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lightbridge Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 398.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.9%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
43.89%
12-Months-Change
Fundamentals
Return on Equity
-15.31%
Trailing 12-Months
Asset Growth
397.73%
Trailing 12-Months
Company Description
Lightbridge
Lightbridge Corporation, together with its subsidiaries, engages in the design and development of nuclear fuel technology under the Lightbridge Fuel name. It focuses on developing and commercializing metallic nuclear fuels that could enhance resistance of nuclear fuel in existing and new nuclear reactors with a meaningful impact on addressing climate change and air pollution. The company was formerly known as Thorium Power, Ltd. and changed its name to Lightbridge Corporation in September 2009. Lightbridge Corporation is headquartered in Reston, Virginia.
LTBR Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong technical progress and a materially improved financial position, highlighted by the start of ATR irradiation testing, validated fabrication milestones, expanded INL scope and technical publications, and a cash balance that increased to $201.9 million (approximately +405% year-over-year) funded largely by a $176.0 million equity raise. At the same time, the company remains pre-commercial with significant regulatory, testing, and licensing work still required, used $14.3 million in operations in fiscal 2025, and faces timeline and execution risks tied to future post-irradiation examination and NRC engagement. Overall, positive execution and funding momentum outweigh near-term development and regulatory uncertainties.View all LTBR earnings summariesTechnical Analysis
Ownership Overview
5.30% Insiders
8.99% Mutual Funds
2.05% Other Institutional Investors
67.65% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---